Document Detail


Complete regression of advanced liposarcoma of the anterior chest wall with interferon-alpha and tumor necrosis factor-alpha.
MedLine Citation:
PMID:  8476203     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
This paper reports a case of complete regression of a liposarcoma in a 62-year-old Japanese man who, in August 1986, presented with a giant subcutaneous tumor of the right anterior chest wall. Local radiotherapy and conventional chemotherapy were initially performed; however, the tumor did not respond at all. He then received cytokine treatment (interferon-alpha and tumor necrosis factor-alpha). Nineteen months after cytokine treatment, the mass disappeared totally. The patient has been in complete remission for five years without recurrence and with no additional treatment. This suggests that the use of interferon-alpha and tumor necrosis factor-alpha in combination may be an effective and promising modality for liposarcomas which are refractory to the conventional anticancer treatments.
Authors:
H Iwagaki; A Hizuta; T Yoshino; T Mannami; F Moriyasu; N Tanaka; K Orita
Related Documents :
11354283 - Iron overload impairs pro-inflammatory cytokine responses by kupffer cells.
21557443 - Par(1) plays a role in epithelial malignancies: transcriptional regulation and novel si...
9419473 - Demonstration of differences in vascular permeability in experimental tumors by use of ...
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Anticancer research     Volume:  13     ISSN:  0250-7005     ISO Abbreviation:  Anticancer Res.     Publication Date:    1993 Jan-Feb
Date Detail:
Created Date:  1993-05-18     Completed Date:  1993-05-18     Revised Date:  2006-04-24    
Medline Journal Info:
Nlm Unique ID:  8102988     Medline TA:  Anticancer Res     Country:  GREECE    
Other Details:
Languages:  eng     Pagination:  13-5     Citation Subset:  IM    
Affiliation:
First Department of Surgery, Okayama University Medical School, Japan.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
Humans
Interferon-alpha / administration & dosage
Liposarcoma / drug therapy*
Male
Middle Aged
Thoracic Neoplasms / drug therapy*
Tumor Necrosis Factor-alpha / administration & dosage
Chemical
Reg. No./Substance:
0/Interferon-alpha; 0/Tumor Necrosis Factor-alpha

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Detection of DNA polymerase-beta gene expression by competitive polymerase chain reaction in human o...
Next Document:  In vitro cytotoxicity and differential cellular sensitivity of new N-methyl and N-propargyl urea and...